This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Aug. 27 Premarket Briefing: 10 Things You Should Know

NEW YORK (TheStreet) -- Here are 10 things you should know for Wednesday, Aug. 27:

1. -- U.S. stock futures rose but European stocks traded flat despite record highs in New York.

Asian shares finished Wednesday's trading session slightly higher. Tokyo's Nikkei 225 Index rose 0.1%.

Read More: Biotech Stock Boom Times Are Back

2. -- The economic calendar in the U.S. on Wednesday includes the MBA Mortgage Index for the week ended Aug. 23 at 7 a.m. EDT.

3. -- U.S. stocks on Tuesday pushed further into record territory, with the S&P 500 hitting new highs and finishing above 2,000 for the first time and the Dow Jones Industrial Average reaching new records of its own.

The Dow rose 0.17% to 17,106.70, after touching a fresh intraday high of 17,153.80. The S&P 500 advanced 0.11% to 2,000.02, trading up to 2,005.04 on Tuesday. The Nasdaq increased 0.29% to 4,570.64.

4. -- Venture-capital firm Kleiner Perkins agreed to invest in message service Snapchat at a valuation of close to $10 billion, people with knowledge of the matter told The Wall Street Journal.

Snapchat, which has talked to several potential investors in recent months, is in the process of raising a large investment round that would make it one of the world's most valuable private tech startups despite virtually no revenue, the Journal noted.

Kleiner committed to invest up to $20 million in May, one of the people said. At least one strategic investor has also committed to invest in the round, which isn't yet closed, two of the people told the newspaper.

5. -- Allergan (AGN - Get Report) , which is fighting off a $49 billion hostile bid from Valeant Pharmaceuticals (VRX) and Pershing Square Capital Management, said it scheduled a special shareholders meeting for Dec. 18, when Pershing Square's Bill Ackman and other shareholders will get the chance to oust the board of the Botox maker.

Allergan consented to the meeting after more than 30% of its shareholders voted in favor of holding the meeting.

Valeant's battle to acquire Allergan has been waging since April.

6. -- Luxury jewelry retailer Tiffany (TIF - Get Report) is expected by Wall Street on Wednesday to report second-quarter earnings of 85 cents a share on revenue of $987.9 million.

7. -- Payments provider Square is in the process of raising capital at a $6 billion valuation, CNBC reported, citing sources familiar with the matter.

The San Francisco-based company, led by Twitter co-founder Jack Dorsey, is aiming to reel in about $200 million, with part of it coming from the Government of Singapore Investment Corporation, the sources told CNBC

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
TIF $87.13 -2.00%
AGN $234.78 -0.03%
GOOG $573.10 -0.09%
TSLA $198.87 -0.35%
YHOO $43.43 1.90%

Markets

DOW 18,097.38 -105.99 -0.58%
S&P 500 2,096.31 -11.47 -0.54%
NASDAQ 4,961.6430 -18.2580 -0.37%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs